胸腺肽联合抗菌药物对老年慢性阻塞性肺疾病急性加重期的治疗效果  

Effect of thymosin combined with antibacterial drugs in treating acute exacerbation of elderly chronic obstructive pulmonary disease

作　　者：庞先琼 赵学会[1] 徐华[1] 

机构地区：[1]四川省西充县人民医院内二科,四川南充637200

出　　处：《检验医学与临床》2015年第13期1922-1923,共2页Laboratory Medicine and Clinic

摘　　要：目的探讨胸腺肽联合抗菌药物对老年慢性阻塞性肺疾病急性加重期(AECOPD)的治疗效果。方法统计分析该院2013年1月至2014年9月收治的60例老年AECOPD患者的临床资料。结果研究组患者的1s用力呼气量(FEV1)和FEV1%均明显高于对照组,差异有统计学意义(P<0.05);临床症状和生活质量评分均明显低于对照组,差异有统计学意义(P<0.05);治疗的总有效率96.7%(29/30)明显高于对照组66.7%(20/30),差异有统计学意义(P<0.05)。结论胸腺肽联合抗菌药物对老年AECOPD的治疗效果明显,值得推广。Objective To investigate the effect of thymosin combined with antibacterial drugs in treating elderly patients with acute exacerbation of chronic obstructive pulmonary disease（AECOPD）.Methods The clinical data in 60 elderly cases of AECOPD admitted to our hospital from January 2013 to September 2014 were statistically analyzed.Results FEV1 and FEV1%in the study group were significantly higher than those in the control group with statistical difference between them（P〈0.05）,the clinical symptoms and quality of life scores in the study group were significantly lower than those in the control group with statistical difference between them（P〈0.05）,the total treatment effective rate in the study group was 96.7%（29/30）,which was significantly higher than 66.7%（20/30）in the control group,the difference was statistically significant（P〈0.05）.Conclusion Thymosin combined with antibacterial drugs has significant effect in the treatment of elderly AECOPD and is worthy of promotion.

关 键 词：胸腺肽 抗菌药物 老年慢性阻塞性肺疾病急性加重期 

分 类 号：R563[医药卫生—呼吸系统]